Fundraising Fox

Caris Life Sciences

NASDAQ: CAI

Founded 1996 · Incorporated in Texas · 1,723 employees on LinkedIn · 4 known investors

Caris Lifesciences operates a precision oncology platform that analyzes DNA, RNA and proteins across tissue and blood to profile a patient's cancer and match treatments and clinical trials. It offers comprehensive molecular profiling tests, including the Caris Detect multi-cancer early detection blood test, for cancer patients and physicians.

AI & Machine LearningBiotechHealthtech

Founders & leadership

Caris Life Sciences was founded in 1996 by David Dean Halbert.

DDDavid Dean Halbert
David Dean HalbertChairman, Founder and CEO

Investors · 4

Coatue ManagementNew York · $1M – $20M
Silver Lake PartnersMenlo Park
Sixth StreetSan Francisco · $50M – $2.5B
OrbiMedreportedNew York · $1M – $75M

Competitors · 1

by search overlap
American Cancer Society (ACS)365 shared keywordsThe American Cancer Society is a nonprofit cancer-fighting organization that combats cancer through advocacy, research, and patient support. It provides information, guidance, caregiver resources, screening guidance, and clinical trial navigation for cancer patients, families, and caregivers, and funds cancer research.

Companies competing with Caris Life Sciences for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Caris Life Sciences do?
Caris Lifesciences operates a precision oncology platform that analyzes DNA, RNA and proteins across tissue and blood to profile a patient's cancer and match treatments and clinical trials. It offers comprehensive molecular profiling tests, including the Caris Detect multi-cancer early detection blood test, for cancer patients and physicians.
Who founded Caris Life Sciences?
Caris Life Sciences was founded by David Dean Halbert in 1996.
Who are Caris Life Sciences's investors?
Caris Life Sciences's investors include Coatue Management, Silver Lake Partners, Sixth Street, OrbiMed.